| Clinical end points in coronary stent trials: a case for standardized definitions DE Cutlip, S Windecker, R Mehran, A Boam, DJ Cohen, GA van Es, ... Circulation 115 (17), 2344-2351, 2007 | 6044 | 2007 |
| Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke JL Saver, M Goyal, A Bonafe, HC Diener, EI Levy, VM Pereira, GW Albers, ... New England Journal of Medicine 372 (24), 2285-2295, 2015 | 5514 | 2015 |
| Transcatheter or surgical aortic-valve replacement in intermediate-risk patients MB Leon, CR Smith, MJ Mack, RR Makkar, LG Svensson, SK Kodali, ... New England Journal of Medicine 374 (17), 1609-1620, 2016 | 4915 | 2016 |
| Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients MJ Mack, MB Leon, VH Thourani, R Makkar, SK Kodali, M Russo, ... New England Journal of Medicine 380 (18), 1695-1705, 2019 | 4005 | 2019 |
| Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document AP Kappetein, SJ Head, P Généreux, N Piazza, NM Van Mieghem, ... Journal of the American College of Cardiology 60 (15), 1438-1454, 2012 | 3805 | 2012 |
| Stenting versus endarterectomy for treatment of carotid-artery stenosis TG Brott, RW Hobson, G Howard, GS Roubin, WM Clark, W Brooks, ... New England Journal of Medicine 363 (1), 11-23, 2010 | 3525 | 2010 |
| Transcatheter mitral-valve repair in patients with heart failure GW Stone, JA Lindenfeld, WT Abraham, S Kar, DS Lim, JM Mishell, ... New England Journal of Medicine 379 (24), 2307-2318, 2018 | 2517 | 2018 |
| Strategies for multivessel revascularization in patients with diabetes ME Farkouh, M Domanski, LA Sleeper, FS Siami, G Dangas, M Mack, ... New England journal of medicine 367 (25), 2375-2384, 2012 | 2132 | 2012 |
| Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents L Mauri, DJ Kereiakes, RW Yeh, P Driscoll-Shempp, DE Cutlip, PG Steg, ... New England Journal of Medicine 371 (23), 2155-2166, 2014 | 2095 | 2014 |
| Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 … AM Lincoff, JA Bittl, RA Harrington, F Feit, NS Kleiman, JD Jackman, ... Jama 289 (7), 853-863, 2003 | 1463 | 2003 |
| Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials DE Cutlip, DS Baim, KKL Ho, JJ Popma, AJ Lansky, DJ Cohen, ... Circulation 103 (15), 1967-1971, 2001 | 1207 | 2001 |
| Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis VH Thourani, S Kodali, RR Makkar, HC Herrmann, M Williams, ... The Lancet 387 (10034), 2218-2225, 2016 | 1127 | 2016 |
| Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry JA Spertus, R Kettelkamp, C Vance, C Decker, PG Jones, JS Rumsfeld, ... Circulation 113 (24), 2803-2809, 2006 | 1093 | 2006 |
| Stenting and medical therapy for atherosclerotic renal-artery stenosis CJ Cooper, TP Murphy, DE Cutlip, K Jamerson, W Henrich, DM Reid, ... New England Journal of Medicine 370 (1), 13-22, 2014 | 1064 | 2014 |
| Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention RW Yeh, EA Secemsky, DJ Kereiakes, SLT Normand, AH Gershlick, ... Jama 315 (16), 1735-1749, 2016 | 916 | 2016 |
| Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization EJ Topol, DJ Moliterno, HC Herrmann, ER Powers, CL Grines, DJ Cohen, ... New England Journal of Medicine 344 (25), 1888-1894, 2001 | 889 | 2001 |
| Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document AP Kappetein, SJ Head, P Généreux, N Piazza, NM Van Mieghem, ... The Journal of thoracic and cardiovascular surgery 145 (1), 6-23, 2013 | 867 | 2013 |
| Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy DS Pinto, AJ Kirtane, BK Nallamothu, SA Murphy, DJ Cohen, RJ Laham, ... Circulation 114 (19), 2019-2025, 2006 | 836 | 2006 |
| Incidence and treatment of'no-reflow'after percutaneous coronary intervention. RN Piana, GY Paik, M Moscucci, DJ Cohen, CM Gibson, AD Kugelmass, ... circulation 89 (6), 2514-2518, 1994 | 802 | 1994 |
| Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison CJ Cooper, RA El-Shiekh, DJ Cohen, L Blaesing, MW Burket, A Basu, ... American heart journal 138 (3), 430-436, 1999 | 797 | 1999 |
Richard E. KuntzHarvard UniversityVerified email at medtronic.com
